Acne is the most common skin condition in the US, affecting up to 50 million Americans annually. Although complex, researchers believe that the interplay between microbes and the host’s immunity is pivotal.

In this whitepaper, we delve into:

• The major pathogenic factors contributing to acne development;

• The intricate relationship between the skin microbiome and acne development;

• The science-backed potential of topical probiotics in addressing skin dysbiosis;

• The evidence on the skin-native probiotic strain BLIS Q24™ for restoring the skin microbiome and its efficacy for inhibiting acne-causing bacteria.

Uncover the power of probiotics for skincare formulation – download now!